ARCHIVES

FDA’s Jane Henney

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Cancer Prevention Grants Awarded To Five States, DC

June 30, 1989

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards

February 12, 1999